These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals. Kim CK; Rivier C J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649 [TBL] [Abstract][Full Text] [Related]
12. The tragedy of TRIUMPH for nitric oxide synthesis inhibition in cardiogenic shock: where do we go from here? Bailey A; Pope TW; Moore SA; Campbell CL Am J Cardiovasc Drugs; 2007; 7(5):337-45. PubMed ID: 17953472 [TBL] [Abstract][Full Text] [Related]
13. Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery. Katz JN; Stebbins AL; Alexander JH; Reynolds HR; Pieper KS; Ruzyllo W; Werdan K; Geppert A; Dzavik V; Van de Werf F; Hochman JS; Am Heart J; 2009 Oct; 158(4):680-7. PubMed ID: 19781431 [TBL] [Abstract][Full Text] [Related]
14. Outcome of patients aged >or=75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent revascularization? Dzavik V; Sleeper LA; Picard MH; Sanborn TA; Lowe AM; Gin K; Saucedo J; Webb JG; Menon V; Slater JN; Hochman JS; Am Heart J; 2005 Jun; 149(6):1128-34. PubMed ID: 15976798 [TBL] [Abstract][Full Text] [Related]
15. Post-myocardial infarction cardiogenic shock is a systemic illness in need of systemic treatment: is therapeutic hypothermia one possibility? Stegman BM; Newby LK; Hochman JS; Ohman EM J Am Coll Cardiol; 2012 Feb; 59(7):644-7. PubMed ID: 22322079 [TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance. Tsagalou EP; Kanakakis J; Anastasiou-Nana MI; Drakos SG; Ntalianis AS; Malliaras K; Lazaris N; Katsaros F; Nanas JN Acute Card Care; 2009; 11(2):99-106. PubMed ID: 19353405 [TBL] [Abstract][Full Text] [Related]
17. [Short and intermediate term clinical outcome in patients with cardiogenic shock treated with aortic counterpulsation]. Fornaro G; Prando MD; Parodi F; Cordero G; Sansa M; Bongo AS; Campi A; Aralda D; Dellavesa P; Aina F; Lazzero M; Cernigliaro C G Ital Cardiol; 1996 Dec; 26(12):1385-99. PubMed ID: 9162668 [TBL] [Abstract][Full Text] [Related]
18. Interhospital transfer for early revascularization in patients with ST-elevation myocardial infarction complicated by cardiogenic shock--a report from the SHould we revascularize Occluded Coronaries for cardiogenic shocK? (SHOCK) trial and registry. Jeger RV; Tseng CH; Hochman JS; Bates ER Am Heart J; 2006 Oct; 152(4):686-92. PubMed ID: 16996836 [TBL] [Abstract][Full Text] [Related]
19. Nitric oxide inhibition rapidly increases blood pressure with no change in outcome in cardiogenic shock: the TRIUMPH trial. Salem R; Mebazaa A Crit Care; 2007; 11(3):136. PubMed ID: 17561988 [TBL] [Abstract][Full Text] [Related]
20. [Cardiogenic shock in acute myocardial infarction--what we know in 2005]. Vojácek J; Bis J Cas Lek Cesk; 2005; 144 Suppl 3():30-2. PubMed ID: 16335260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]